Canada· CA-DIN-02299364

RIVA-OXYBUTYNIN

A oxybutynin product containing oxybutynin chloride, registered in Canada by LABORATOIRE RIVA INC.. The same ATC class is registered in 18 of our 19 countries.

ATC G04BD04

Checked against Health Canada Drug Product Database (Canada) on

Informational only — not a medical device.

SOURCE REGISTER · CAHealth Canada Drug Product Database (Ca…normalisedRIVA-OXYBUTYNINATCG04BD04REGISTER NO.CA-DIN-02299364PACKS LISTED0CHECKEDOctober 1, 2026

Where it is registered

Oxybutynin is registered in 18 of 19 countries.

Countries holding a registration under ATC G04BD04 (oxybutynin), each read from that country’s own register.

  • This record: Canada, from Health Canada Drug Product Database (Canada)
  • 10 of them publish a price we can compare per daily dose

Oxybutynin · ATC G04BD04

18 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Italyprice
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of oxybutynin costs, country by country.

Normalised to the WHO defined daily dose (15 mg), the median price runs from $0.17 in France to $2.99 in Switzerland — a ×18 gap.

  • 4 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
  • US figures are pharmacy acquisition cost (CMS NADAC), not retail

Oxybutynin · price per daily dose (15 mg)

USD · FX 28 Sept 2026

  • CH Switzerland$2.99
  • IT Italy$0.59
  • US United States$0.20 (acquisition cost)
  • FR France$0.17
Median listed price per WHO defined daily dose, in each market that publishes a price. US = pharmacy acquisition cost (CMS NADAC), not a retail price. Open the full comparison

The record

At a glance

Health Canada Drug Product Database (Canada)
Active substance
OXYBUTYNIN CHLORIDE
Manufacturer
LABORATOIRE RIVA INC.
Country
Canada (CA)
ATC code
G04BD04
ATC class
Oxybutynin
Defined daily dose
15 mg, O
Reimbursed
Not published by this register
Source register
Health Canada Drug Product Database (Canada)
Last checked
October 1, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

312 interactions on record for oxybutynin.

Graded by severity as the source publishes them — 3 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Oxybutynin · interactions on record

312 records

  • 3 severe
  • 103 moderate
  • 1 minor
  • 168 info

Most severe, free to view

  • Potassium chlorideA12BA01severe
  • Potassium citrateA12BA02severe
  • Potassium chlorideB05XA01severe
  • DicycloverineA03AA07moderate

37 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Oxybutynin in 17 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All oxybutynin products

Authorised across Europe · EMA

The same active substance is authorised in 27 EEA countries. Names it is sold under:

  • Austria · Detrusan, Ditropan
  • Belgium · Oxybutynine Eg, Velariq
  • Bulgaria · Дриптан
  • Czechia · Tarraconiq, Uroxal
  • Germany · Dridase, Oxybutynin Aaa-Pharma
  • Denmark · Oxybutynin Macure, Oxybutynin Unimedic
  • Estonia · Driptane
  • Spain · Ditropan, Dresplan
  • Finland · Oxybutynin Macure, Oxybutynin Unimedic
  • France · Ditropan, Oxybutynine Accord
  • United Kingdom (Northern Ireland) · Ditropan, Oxybutynin Hydrochloride
  • Greece · Ditropan
  • Hungary · Ditropan, Uroxal
  • Ireland · Oxybutynin Hydrochloride Accord Healthcare Ireland, Oxybutynin Hydrochloride Syri Pharma
  • Iceland · Kentera
  • Italy · Ditropan, Ossibutinina Cloridrato Mylan Generics
  • Liechtenstein · Kentera
  • Lithuania · Driptane
  • Luxembourg · Oxybutynine Eg, Velariq
  • Latvia · Driptane
  • Netherlands · Dridase, Oxybutinin Hydrochloride Aurobindo
  • Norway · Kentera, Oxybutynin Macure
  • Poland · Ditropan, Driptane
  • Portugal · Ditropan, Velariq
  • Romania · Driptane
  • Sweden · Ditropan, Oxybutynin Accord
  • Slovakia · Uroxal, Velariq

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Health Canada Drug Product Database (Canada). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/c2b2f5f6-b2e5-4e01-b1a4-adca8394b0e9
GET /v1/drugs/c2b2f5f6-b2e5-4e01-b1a4-adca8394b0e9?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "din": "02299364",
  "form": "TABLET",
  "class": "Human",
  "routes": [
    "ORAL"
  ],
  "source": "health_canada_dpd",
  "status": "MARKETED",
  "atc_raw": "G04BD04",
  "schedule": [
    "Prescription"
  ],
  "drug_code": "78474",
  "strengths": [
    "5 MG"
  ],
  "ahfs_class": null,
  "substances": [
    "OXYBUTYNIN CHLORIDE"
  ],
  "product_categorization": null
}

See everything about oxybutynin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.